Animal Model Ms
Animal Model Ms - Related Videos
26:43
Computer-Generated Animal Model Stimuli
0 Views •
Cited by 8 •
2007
Computer-generated stimuli using the Jacky dragon as a model.
09:45
An Isolated Working Heart System for Large Animal Models
0 Views •
Cited by 22 •
2014
Most studies involving the Langendorff apparatus use small animal models due to the increased complexity of systems for larger mammals. We describe a Langendorff system for large animal models that allows for use across a range of species, including humans, and relatively easy data acquisition.
07:02
Animal Model of Implant-Associated Infections in Mice
0 Views •
2025
The present protocol describes a mouse model employing subcutaneous dorsal implantation to investigate implant-associated infections, enabling comprehensive investigation of pathophysiological mechanisms and supporting the development of diagnostic criteria with targeted therapeutic strategies.
05:36
Kidney Procurement in a Preclinical Large Animal Model
0 Views •
2025
Here, we present a protocol that details a surgical model for kidney procurement in a preclinical swine model for subsequent machine perfusion or transplantation.
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
0 Views •
Cited by 13 •
2012
Sepsis refers to a systemic inflammatory response syndrome resulting from a microbial infection, and can be simulated by a surgical technique termed cecal ligation and puncture (CLP). Here we describe a method to use CLP-induced animal model to screen medicinal herbs for therapeutic agents.
FAQs
Sensitization to myelin-associated antigens activates immune cells that recognize components of nervous tissue. Once these autoreactive cells enter the central nervous system, they promote local inflammation and damage to myelin, disrupting normal neural function. The resulting neurological impairment allows investigators to connect immune activation with tissue injury and observable disease progression.
Crossing the blood-brain barrier marks a critical transition from peripheral immune activation to central nervous system injury. It permits autoreactive immune cells to reach neural tissues, where inflammation can affect myelin and contribute to axonal damage. Studying this transition helps researchers investigate how immune responses become linked to neurological impairment in MS biology.
These systems can reproduce selected features such as central nervous system inflammation, demyelination, neurological impairment, and inflammation-associated axonal injury. However, no model reproduces every aspect of human MS. This limitation means that results should be interpreted as evidence about particular disease mechanisms rather than as a complete representation of the human condition.
Animal models allow investigators to examine how inflammation relates to different forms of nervous system damage, including demyelination and axonal injury. Tracking these outcomes helps clarify whether immune activity is associated only with early inflammatory changes or also with more consequential tissue injury. Such distinctions are important when studying disease progression and potential therapeutic targets.
A study generally begins by selecting a susceptible animal system and sensitizing it to a myelin-associated antigen. Researchers then examine the development of central nervous system inflammation, demyelination, and neurological impairment. These observations can be used to connect immune activation with disease features and to assess how an experimental intervention changes the resulting biology.
Researchers use these models when they need to test whether a candidate drug affects immune mechanisms or disease-associated outcomes before drawing conclusions about human MS. Treatment studies can examine changes in inflammation, demyelination, neurological impairment, or related tissue injury. Positive findings identify promising directions, but they still require comparison with clinical evidence and human tissue studies.
Comparison with clinical observations and human tissue studies helps determine which findings reflect shared MS biology and which may be specific to the laboratory system. Because animal models reproduce selected features rather than the entire disease, this broader interpretation reduces overgeneralization. It also supports more cautious assessment of therapeutic targets and mechanisms identified experimentally.